NCT02242058View on ClinicalTrials.gov

QST-Pupillometry in Sickle Cell Disease Patients

CompletedOBSERVATIONAL
Enrollment

96

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

November 30, 2018

Study Completion Date

November 30, 2018

Conditions
SCD With Severe Phenotype (HbSS, HbSβ0 Thalassemia, HbSOARab)
Interventions
OTHER

Quantitative sensory testing

Trial Locations (2)

20010

Children's National Health System, Washington D.C.

Children's National Medical Center, Washington D.C.

All Listed Sponsors
lead

Julia Finkel

OTHER

NCT02242058 - QST-Pupillometry in Sickle Cell Disease Patients | Biotech Hunter | Biotech Hunter